Related Experiment Video
Updated: Feb 20, 2026

Surgical Swine Model of Chronic Cardiac Ischemia Treated by Off-Pump Coronary Artery Bypass Graft Surgery
Published on: March 27, 2018
Does HbA1c Level Have Clinical Implications in Diabetic Patients Undergoing Coronary Artery Bypass Grafting? A
Jia Zheng1, Jing Cheng2, Tong Wang1
1Department of Endocrinology, Key Laboratory of Endocrinology, Ministry of Health, Peking Union Medical College Hospital, Diabetes Research Center of Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
Insights
Higher hemoglobin A1c (HbA1c) levels in diabetic patients undergoing coronary artery bypass grafting (CABG) surgery are linked to increased risks of death, heart attack, and stroke. Further research is needed to confirm these findings.
Area of Science:
- Cardiology
- Endocrinology
- Surgical Outcomes
Background:
- Diabetes mellitus is a significant comorbidity in patients undergoing cardiovascular surgery.
- Glycemic control, measured by hemoglobin A1c (HbA1c), is a critical factor in diabetic patient management.
- The impact of preoperative HbA1c levels on clinical outcomes after coronary artery bypass grafting (CABG) requires further elucidation.
Purpose of the Study:
- To investigate the association between preoperative HbA1c levels and clinical outcomes in diabetic patients undergoing CABG surgery.
- To synthesize evidence from existing literature to quantify the risks associated with elevated HbA1c in this patient population.
Main Methods:
- A comprehensive literature search was conducted across PubMed, Embase, and Cochrane Library databases.
- Inclusion criteria were applied to identify relevant studies on diabetic patients undergoing CABG.
- Data were analyzed using meta-analysis, expressing differences as odds ratios (ORs) with 95% confidence intervals (CIs).
Main Results:
- The meta-analysis included 7,895 diabetic patients from eight studies.
- Higher HbA1c levels were significantly associated with increased risks of all-cause mortality (OR 1.56, 95% CI 1.29-1.88).
- Significantly elevated risks were also observed for myocardial infarction (OR 2.37, 95% CI 1.21-4.64) and stroke (OR 2.07, 95% CI 1.29-3.32).
- No significant relationship was found between HbA1c levels and renal failure (OR 2.08, 95% CI 0.96-4.54).
Conclusions:
- Elevated HbA1c levels are associated with increased risks of mortality, myocardial infarction, and stroke in diabetic patients following CABG surgery.
- These findings highlight the importance of glycemic control in optimizing surgical outcomes.
- Further large-scale clinical studies with extended follow-up are warranted to confirm these associations.
Aims/Introduction:
The aim of the present study was to investigate whether HbA1c was related to clinical outcomes in diabetic patients undergoing CABG surgery.
Materials And Methods:
A literature search was carried out satisfying the predefined inclusion criteria from Pubmed, Embase, and Cochrane Library. Differences were expressed as odds ratios (ORs) with 95% confidence intervals (CIs) to assess the relationships of preoperative HbA1c levels and clinical prognosis in diabetic patients.
Results:
7895 diabetic patients undergoing CABG surgery from eight published studies were finally involved in this meta-analysis. Combined analyses revealed that the higher HbA1c level was significantly associated with increased risks of all-cause mortality (OR 1.56, 95%CI 1.29-1.88), myocardial infarction (OR 2.37, 95%CI 1.21-4.64), and stroke (OR 2.07, 95%CI 1.29-3.32) after CABG surgery. However, there was no significant relationship between HbA1c levels and renal failure (OR 2.08, 95%CI 0.96-4.54) in diabetic patients undergoing CABG surgery.
Conclusions:
Our meta-analysis demonstrated that the HbA1c level is potentially associated with increased risks of all-cause mortality, myocardial infarction, and stroke in diabetic subjects undergoing CABG surgery. However, further clinical studies with larger sample sizes and longer follow-up period are urgently warranted.
Related Concept Videos
Coronary Artery Disease I: Introduction
Coronary Artery Disease V: Interprofessional Care
Coronary Artery Disease IV: Preventive Measures
Diabetes Mellitus: Type 2 and Gestational
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Cardiomyopathy III: Hypertrophic Cardiomyopathy

